Glioblastoma stem cells after treatment with HLM006474, S3I-201 or their combination.
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189781
下载链接
链接失效反馈官方服务：
资源简介：
Malignant gliomas, including glioblastoma (GBM), are uniformly lethal with inferior prognosis and lack of effective treatment. Although the H2AZ2 variant histone is overexpressed in diverse cancer types where it promotes cancer cell proliferation, there are no H2AZ2 inhibitors to-date for clinical intervention. Here, we explored approaches to pharmacologically target the H2AZ2-dependent pathways in GBM. RNA-seq from glioblastoma stem cell specimens (TS-543) following treatment with DMSO, HLM006474, S3I-201 or combination of HLM006474 and S3I-201.
创建时间：
2022-08-02
